Tcrcure Biopharma Ltd.
Clinical trials sponsored by Tcrcure Biopharma Ltd., explained in plain language.
-
New CAR-T therapy targets tough lung cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called TC-D101 for people with a specific type of advanced small cell lung cancer that has not responded to standard therapies. The treatment uses the patient's own immune cells, modified to attack cancer cells carrying a protein calle…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 17, 2026 05:37 UTC
-
Engineered t cells take on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new type of immune cell therapy (CAR-T) designed to target a protein called ALPP found on some advanced solid tumors. About 24 adults whose cancers have not responded to standard treatments will receive the therapy to see if it is safe and tolerable…
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 04, 2026 16:24 UTC